Novavax to Present at the Stifel 2015 Healthcare Conference
11 November 2015 - 8:05AM
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company
focused on the discovery, development and commercialization of
recombinant nanoparticle vaccines and adjuvants, today announced
that Barclay “Buck” Phillips, SVP, Chief Financial Officer and
Treasurer, will present at the Stifel 2015 Healthcare Conference.
Conference details are as follows:
Date: Tuesday, November 17, 2015Time: 4:30 p.m.
US Eastern TimeLocation: New York Palace Hotel, New York CityLive
webcast:
http://www.veracast.com/webcasts/stifel/healthcare2015/86112760876.cfm
The webcast and a replay of the presentation
will also be accessible under the “Investors/Events” section of the
Novavax website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Our recombinant nanoparticles
and Matrix-M™ adjuvant technology are the foundation for
groundbreaking innovation that improves global health through safe
and effective vaccines. Additional information about Novavax is
available on the Company’s website, novavax.com.
Contact: Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2024 to May 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From May 2023 to May 2024